规格参数
| 项目 | 产品信息 |
|---|---|
| 多核苷酸（PN） | 10 mg |
| 低分子量HA | 10 mg |
| 包装形式 | 2.5 mL |
技术参考
资料区分 PN（多核苷酸）与 PDRN（聚脱氧核糖核苷酸），并介绍 PN 在保湿、组织支撑及肤质研究中的背景，以及 HA–PN 在实验性皮肤模型中的研究。这些属于成分层面的参考资料，并非此成品的临床试验。
完整英文原始详情
下方保留产品指南的完整英文文本。上方本地化介绍及规格表是对资料的结构化整理；PDF 保留制造商或来源的原始文件。
Si Belle HydraNoor PN combines 10 mg polynucleotide (PN) with 10 mg low-molecular-weight hyaluronic acid (HA) in a 2.5 mL presentation.
Product composition
The formulation combines polynucleotide (PN) and low-molecular-weight hyaluronic acid (HA).
Polynucleotide is the DNA-derived polymer component. Hyaluronic acid is the second component in the PN + HA formulation.
| Component | Amount | Description |
|---|---|---|
| Polynucleotide (PN) | 10 mg | DNA-derived polymer component |
| Hyaluronic acid (HA) | 10 mg | Low molecular weight |
| Presentation | 2.5 mL | Si Belle HydraNoor PN |
Understanding PN and PDRN
PN means polynucleotide. PDRN means polydeoxyribonucleotide. These names identify different types of DNA-derived preparations and should not be used interchangeably.
| Topic | PN | PDRN |
|---|---|---|
| Full name | Polynucleotide | Polydeoxyribonucleotide |
| General source context | DNA-derived polymers discussed in skin-quality research | DNA-derived preparations discussed in tissue-repair research |
| Literature emphasis | Hydration, tissue support and skin-quality endpoints | Nucleotide metabolism and wound-related endpoints |
| Interpretation | Composition, molecular size and purification depend on the preparation | Class-level findings do not replace product-specific clinical data |
PN + HA formulation concept
The supplied catalogue explains the PN component in relation to skin-quality and tissue-support research, and the HA-PN combination in relation to experimental skin models.
The product profile is 10 mg PN plus 10 mg low-molecular-weight HA in 2.5 mL.
专业业务咨询
请注明公司、目的国、所选型号及数量。此操作将打开邮件应用，不会自动发送或保存咨询。
alexmoon@ictmedicalco.com ↗